FDA Inspection 1002801 — Advancing Sight Network Southeast Regional Office
The FDA completed an inspection of Advancing Sight Network Southeast Regional Office on December 7, 2016 in Montgomery, AL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 7, 2016
- Fiscal Year
- 2017
- Product Type
- Biologics
- Project Area
- Human Cellular, Tissue, and Gene Therapies
- Location
- Montgomery, AL (United States)